Version for the visually impaired:
Font size:
a
a
a
Language version:
en
Visit website TNRMC

Personalities

Polina A. Gervas

Polina A. Gervas

Polina A. Gervas, PhD, Senior Researcher, Cancer Research Institute, Tomsk NRMC.

Contact details

e-mail: gervaspa@oncology.tomsk.ru,

            pgervas@yandex.ru

tel: +7 (3822)282686*3345

Brief CV

Work experience

2009 – 2019: Senior Researcher, Laboratory of Molecular Oncology and Immunology, Cancer Research Institute, Tomsk NRMC
2007-2008: Junior Researcher, Laboratory of Immunology, Cancer Research Institute, SB RAMS
2003 – 2006: Technician, Laboratory of Immunology, Cancer Research Institute, SB RAMS

2001-2002: PhD student, Immunomodulation Research Centre, Sought Korea, Ulsan

Education

2013-2014: Clinical Laboratory Diagnostic in Siberian State Medical University
2003-2007: PhD in Oncology, Cancer Research Institute of the Scientific Center of the Siberian Branch of the Russian Academy of Medical Sciences
1995-2001: MD in biochemistry, Siberian State Medical University, Tomsk (SSMU)

Awards:

2006     Silver sponsorship, 16th European Respiratory Society Annual Congress, Munich, Germany

2007      Travel Grant Recipient, IASLC 12th World Conference on Lung Cancer, Seoul, South Korea

2008      Traineeship, Roswell Park Cancer Institute, Buffalo, NY, USA

2013     Awarded For The Best Abstract, UAE Cancer Congress 2013, Dubai, UAE

Publications

The current list of publications: PubMed

Selected publications

1.      Denisov E.V., Schegoleva A.A., Gervas P.A., Ponomaryova A.A., Tashireva L.A., Boyarko V.V., Bukreeva E.B., Pankova O.V., Perelmuter V.M. Premalignant lesions of squamous cell carcinoma of the lung: The molecular make-up and factors affecting their progression. Lung Cancer 2019;135:21-28.

2.      Gervas P, Klyuch B, Denisov E, Kiselev A, Molokov A, Pisareva L, Malinovskaya E, Choynzonov E, Cherdyntseva N. New germline BRCA2 gene variant in the Tuvinian Mongol breast cancer patients. Mol Biol Rep. 2019 Oct;46(5):5537-5541. doi: 10.1007/s11033-019-04928-y.

3.      Gervas P., Ivanova A., Vasiliev N., Ananina O., Zharkova O., Rogovieva O., Verzhbitskaya N., Didichuk I., Cheremisina O., Popova N., Goldberg V., Cherdyntsev E., Choynzonov E., Cherdyntseva N.. Frequency of EGFR Mutations in Non-small Cell Lung Cancer Patients: Screening Data from West Siberia // Asian Pac J Cancer Prev. – 2015. – Vol. 16(2). – P.689-92. IF - 2,5 Scopus https://www.ncbi.nlm.nih.gov/pubmed/25684509

4.      Imyanitov E.N., Demidova I.A., Gordiev M.G., Filipenko M.L., Kekeyeva T.V., Moliaka Y.K., Gervas P.A., Kozhemyako V.B., Vodolazhskiy D.I., Sergeyeva L.A., Fattakhova D.U., Iyevleva A.G., Mitiushkina N.V., Kuligina E.Sh., Barinov A.A., Mommaeva M.S., Aleksakhina S.N., Tsimafeyeu I.V., Tjulandin S.A. Distribution of EGFR Mutations in 10,607 Russian Patients with Lung Cancer // Mol. Diagn. Ther. – 2016. – Vol. 20(4). – P. 401-6. doi: 10.1007/s40291-016-0213-4. IF – 2,602, WOS/SCOPUS https://www.ncbi.nlm.nih.gov/pubmed/27259329

5.      Cherdyntseva N., Gervas P., Voropaeva E., Denisov E., Pisareva L., Malinovskaya E., Maksimov V., Voevoda M., Perinov D., Panferova Y., Cherdyntsev E., Choynzonov E. New variants in the BRCA1 gene in Buryat Mongol breast cancer patients: Report from two families // Cancer Biomark. – 2017, 18(3). – P. 291-296. - doi: 10.3233/CBM-161649. IF=2,274 WOS/Scopus https://www.ncbi.nlm.nih.gov/pubmed/27983536

6.      Cherdyntseva N.V., Litviakov N.V., Denisov E.V., Gervas P.A., Cherdyntsev E.S. Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects // Exp Oncol. – 2017. – Vol.39(1). – P.2-11. https://www.ncbi.nlm.nih.gov/pubmed/28361862. IF - 0,95 SCOPUS https://www.ncbi.nlm.nih.gov/pubmed/28361862

7.      Antontseva Elena V., Matveeva Marina YU., Bondar Natalia P., Kashina Elena V., Leberfarb Elena YU., Bryzgalov Leonid O., Gervas Polina A., Ponomareva Anastasia A., Cherdyntseva Nadezhda V., Orlov Yury L., Merkulova Tatiana I. Regulatory single nucleotide polymorphisms at the beginning of intron 2 of the human KRAS gene // Journal of Biosciences. – 2015. – Vol.40(5). – P. 873-83. IF - 2,0 WOS https://www.ncbi.nlm.nih.gov/pubmed/26648033

8.      Cherdyntseva NV, Pisareva LF, Ivanova AA, Panferova YV, Malinovskaya EA, Odintsova IN, Doroshenko AV, Gervas PA, Slonimskaya EM, Shivit-ool AA, Dvornichenko VV, Choinzonov YL. Ethnic aspects of hereditary breast cancer in the region of Siberia. Vestn Ross Akad Med Nauk. 2014;(11-12):72-9. Russian.

9.      Babyshkina N., Malinovskaya E., Nazarenko M., Koval M., Gervas P., Potapova O., Slonimskaya E., Cherdyntseva N. The effect of folate-related SNPs on clinicopathological features, response to neoadjuvant treatment and survival in pre- and postmenopausal breast cancer patients // Gene. – 2013. – Vol.518(2). – P.397-404. IF=2,415 WOS/Scopus https://www.ncbi.nlm.nih.gov/pubmed/23296054

10. Cherdyntseva N.V., Gervas P.A., Litvyakov N.V., Stakcheeva M.N. Аge-related function of tumor suppressor gene tp53: contribution to cancer risk and progression // Exp Oncol 2010 32, 3, 205–208. https://www.ncbi.nlm.nih.gov/pubmed/21403619

11. Butorin I.Yu., Cherdyntseva N.V., Gervas P.A., Murase H., Kagiya V.T.. Effect of tocoferol-monoglucoside (TMG), a water-soluble glycosylated derivative of vitamin E, on hematopoietic recovery in irradiated mice // J. Rad. Res.,Vol.46, №1.-2005.-С.37-41. https://www.ncbi.nlm.nih.gov/pubmed/15802857